Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group
about
sameAs
Selenium supplementation for critically ill adultsSelenium supplementation for critically ill adultsThiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in DrosophilaA safe lithium mimetic for bipolar disorderNeuroprotection for ischemic stroke: past, present and futureDivalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neuronsOxidative Stress in Diabetic Nephropathy with Early Chronic Kidney DiseaseCerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion InjuryOxidative Stress and the Use of Antioxidants in StrokeNADPH oxidase in stroke and cerebrovascular diseaseEvolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementAntioxidants: The new frontier for translational research in cerebroprotectionPathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2Pharmacology of iron transportComparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruziInactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric InhibitorsAdvances in the Microbiome: Applications to Clostridium difficile InfectionThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingA target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activityEffect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia-ischemia in neonatal rats.Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.What animal models have taught us about the treatment of acute stroke and brain protection.Selenium-containing 15-mer peptides with high glutathione peroxidase-like activity.Advances in ischemic stroke treatment: neuroprotective and combination therapies.Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion.Protection against peroxynitrite.Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.New insights on NOX enzymes in the central nervous system.Neuroprotection in acute ischaemic stroke. II: Clinical potential.Molecular Dissection of Cyclosporin A's Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury.Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitorsEbselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidantAntiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouseSelenite stimulates mitochondrial biogenesis signaling and enhances mitochondrial functional performance in murine hippocampal neuronal cellsXAS studies of Se speciation in selenite-fed rats.Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.Selenium-based pharmacological agents: an update.Neuroprotective agents for the treatment of acute ischemic stroke.
P2860
Q24186311-4460A2F8-58D2-48CD-9F66-68AA9EEDDBB0Q24246013-397CE673-E3C0-4352-9650-9CA5AF8DFC5AQ24322678-29C542C5-773A-46F4-821B-2A111C245CACQ24322678-A4465C29-A16B-4B3F-9D6F-C8A7E249C061Q24600175-6DCE55C3-20F7-4A04-B91E-621E80D9285BQ24600175-D3B3C86D-A331-4D35-87C5-C10C8BC56053Q24645185-9DAFF9B4-599B-44F4-BB9C-B748360785DBQ24645185-D224115C-D67A-4F5E-A755-2824615F3C09Q24657218-049EC090-1EFA-4395-BEBD-E96DDFA10C26Q24657218-ED413F81-0FA7-4A7F-B2E9-383B4B689969Q26741451-9CDEB373-C050-433F-8DFF-E2A6C8729E72Q26741451-CAE7330C-022A-4039-B748-A6254D721426Q26751153-07428ED8-B99F-4C38-9D14-0A0EAE8EB8EDQ26751153-5B140494-F16F-4664-BC16-DBC76AD9400BQ26770727-8FDEE446-08EE-4888-94C5-29D3E47C611AQ26770727-E5253185-E4CE-4E41-98F5-0DBC355D7ACAQ26852796-06831309-6235-4548-A6C6-A873C659D3C0Q26852796-3901637B-DDB2-487C-ADDA-4A9B8745BA6FQ26859140-5D015127-BA5A-4AB8-B3A9-B0F5E87E9B77Q26859140-9A4D698C-5A77-4270-B070-599264400D32Q26861119-8876A4C0-4D5E-4069-806D-EB6A2DBE5393Q26861119-E3775E4E-9155-4FCB-B229-EA13F9767F8DQ26863595-9F40DFCB-B0EF-44C5-9536-B637C2DD77E0Q26863595-AFA57CDE-C518-4677-B014-0799497AF3A7Q27005956-2AB99CAE-60D6-4D5E-9C52-A0AA3DDEED10Q27005956-2DEB8180-2678-44C4-93AD-8EC7C395C1E7Q27009387-4878150A-EE37-4413-83A5-8E8ECE2FD6D2Q27009387-7B0D26A3-9467-4113-80B5-5B3BB7CE2F32Q27657406-073B755F-DA2D-400D-9D42-36321740C4C8Q27657406-7B1C1395-FBBD-461F-A790-E17AF67798DCQ27684704-291457E3-486C-427B-875E-DF6185124DF0Q27684704-8D9A4A11-041C-4AF3-A7E0-FF8DA33F4C40Q28066362-25DFAC01-5F5D-4C34-9889-EBD0D11B28EBQ28066362-9CA5F6A7-7E00-4353-A3BB-1DF58A38D8AAQ28389739-65055C68-D575-4063-B11A-089696083F09Q28389739-CA6203D5-1ADF-4733-9F2B-B3D11E5F9F97Q28473648-63BFB931-CBF8-4063-B38D-E0A7E9318C6CQ28473648-BAB41D1D-0EF5-4FDB-B62E-B61B5D66C1CEQ30374052-61D19D24-8E28-4489-B99E-1172F0F28B0FQ30409756-BFC60A81-DC61-49C4-8616-81DA12F54233
P2860
Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@ast
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@en
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@nl
type
label
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@ast
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@en
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@nl
altLabel
Ebselen in Acute Ischemic Stroke : A Placebo-Controlled, Double-blind Clinical Trial
@ast
Ebselen in Acute Ischemic Stroke : A Placebo-Controlled, Double-blind Clinical Trial
@en
prefLabel
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@ast
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@en
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@nl
P2093
P3181
P356
P1433
P1476
Ebselen in Acute Ischemic Stroke : A Placebo-Controlled, Double-blind Clinical Trial
@en
Ebselen in acute ischemic stro ...... cal trial. Ebselen Study Group
@en
P2093
H Yasuhara
H. Yasuhara
K Takakura
K. Takakura
T Yamaguchi
P3181
P356
10.1161/01.STR.29.1.12
P407
P577
1998-01-01T00:00:00Z